Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Quick facts

Marketed products

• Amlodipine/Atorvastatin · Cardiovascular
  This combination drug reduces blood pressure by blocking calcium channels in blood vessels and lowers cholesterol by inhibiting HMG-CoA reductase.
• Atorvastatin and Omega-3 fatty acids
• Blood samples for the analysis of sildenafil in plasma
• Detrol LA · Urology
  Detrol LA is a muscarinic receptor antagonist that blocks acetylcholine signaling in the bladder to reduce involuntary muscle contractions and urinary urgency.
• Diclofenac + Omeprazole · Rheumatology / Gastroenterology
  Diclofenac inhibits prostaglandin synthesis to reduce inflammation and pain, while omeprazole suppresses gastric acid production to protect against NSAID-induced ulcers.
• Doxazosin mysylate GITS · Cardiovascular; Urology
  Doxazosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow, and also dilates blood vessels to lower blood pressure.
• Ibuprofen plus Omeprazole · Pain management / Gastroenterology
  Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while omeprazole protects the stomach by suppressing gastric acid production.
• iso- 5 - mononitrate · Cardiovascular
  Isosorbide 5-mononitrate is a nitrate vasodilator that releases nitric oxide to relax vascular smooth muscle and improve blood flow.
• latanoprost 0.005% ophthalmic solution
• Lyrica (pregabalin) · Neurology; Pain Management; Psychiatry
  Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
• Non-selective NSAIDS · Pain Management, Rheumatology, Cardiovascular
  Non-selective NSAIDs inhibit both COX-1 and COX-2 enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.
• Oxybutynin ER · Urology / Neurology
  Oxybutynin is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity.
• Placebo and celecoxib · Rheumatology / Pain Management
  Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.
• pregabalin and celecoxib
• tolterodine SR, overactive bladder
• Travoprost 004% sterile ophthalmic solution · Ophthalmology
  Travoprost is a prostaglandin F analog that binds to prostaglandin F (FP) receptors in the eye to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure.
• Viagra (sildenafil citrate) · Urology / Cardiovascular
  Sildenafil inhibits phosphodiesterase type 5 (PDE5), allowing cyclic GMP to accumulate and promote smooth muscle relaxation in the corpus cavernosum, increasing blood flow to the penis.
• Xalacom · Other
• Xalatan · Cardiovascular
• ziprazidone · Other
• Zoloft tablets · Psychiatry / Neurology
  Zoloft selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.

Phase 3 pipeline

• celecoxib and ibuprofen SR
• fixed combination latanoprost-timolol · Ophthalmology
  Latanoprost-timolol is a fixed combination of a prostaglandin analog and a beta-blocker that works by reducing intraocular pressure in the eye.
• Geodon (Ziprasidone) · Psychiatry
  Ziprasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.
• Intramuscular ziprasidone mesylate · Psychiatry
  Ziprasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.
• iv sildenafil · Urology
  Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis to treat erectile dysfunction.
• placebo and pregabalin · Pain, Anxiety
  Pregabalin is a structural analog of the neurotransmitter gamma-aminobutyric acid (GABA) and acts as a GABA receptor agonist.
• Placebo matched with pregabalin · Neurology
  Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
• Pregabalin add-on therapy · Neurology
  Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
• Pregabalin Dose Level 1 · Neurology; Pain Management; Psychiatry
  Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
• Pregabalin Dose Level 2 · Neurology; Pain Management; Psychiatry
  Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
• sildenafil citrate (UK-92,480)
• unfixed Latanoprost and Timolol · Ophthalmology
  Latanoprost is a prostaglandin analogue that reduces intraocular pressure by increasing uveoscleral outflow, while Timolol is a beta-adrenergic receptor blocker that reduces intraocular pressure by decreasing aqueous humor production.

Phase 2 pipeline

• Doxazosin mesylate GITS
• [S,S]-reboxetine monotherapy
• Selara · Other

Phase 1 pipeline

• alprazolam sublingual tablet
• Amlodipine ODT - test
• Amlodipine - reference
• Atorvastatin pediatric appropriate formulation
• Atorvastatin pediatric formulation
• B16 Fasted
• B16 Fed
• celecoxib reference formulation
• celecoxib test formulation A1
• celecoxib test formulation B2
• celecoxib test formulation C1
• Commercial tablet with water
• Eletriptan commercial tablet
• Epamin · Other
• Epamin: Reference Drug
• Formulation D ODT tablet 50 mg
• JZoloft
• Nicergoline from China
• Nicergoline from Italy
• ODT #1 with water
• ODT #1 without water
• ODT #2 with water
• ODT #2 without water
• Sequence 2 - Treatment D: Controlled Release Pregabalin
• Sequence 4 - Treatment A: Controlled Release Pregabalin
• Sequence 4 - Treatment B: Controlled Release Pregabalin
• sertraline ODT
• Sildenafil ODT
• Test formulation D1
• Test formulation D2
• Test formulation D3

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Pfizer's Upjohn has merged with Mylan to form Viatris Inc. portfolio CI brief
• Pfizer's Upjohn has merged with Mylan to form Viatris Inc. pipeline updates RSS

Frequently asked questions about Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Related

• Amlodipine/Atorvastatin · Cardiovascular
• Atorvastatin and Omega-3 fatty acids
• Blood samples for the analysis of sildenafil in plasma
• Detrol LA · Urology
• Diclofenac + Omeprazole · Rheumatology / Gastroenterology
• Sector hub: All tracked pharma companies